Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 19 (RN7SKP19) is a pseudogene of the 7SK small nuclear RNA gene (RN7SK). Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically do not produce a functional RNA or protein product. The parent gene, RN7SK, codes for a small nuclear RNA that regulates transcription elongation by RNA polymerase II, but RN7SKP19 itself is not believed to be transcribed into a functional RNA nor to participate in biological processes, disease, or drug interactions[2][3][4][5]. The RN7SK gene encodes a non-coding RNA involved in negative regulation of transcription elongation by binding and sequestering the CDK9/cyclin T complex, but RN7SKP19 is a pseudogene and does not perform this function[3][5]. Pseudogenes like RN7SKP19 are common in the genome; most are unexpressed and non-functional copies of genes[1][2]. There are no known associations with diseases, drugs, or diagnostic biomarkers for this pseudogene[2][3]. This gene is not considered a valid therapeutic target or relevant for functional molecular classification. Any entry listing RN7SKP19 as a druggable target is likely incorrect or misinformed[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 19 (RN7SKP19).